Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2011 1
2012 1
2013 1
2014 1
2015 1
2018 1
2019 1
2020 1
2021 1
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Sickle Cell Disease in Brazil: Current Management.
da Silva Araújo A, Silva Pinto AC, de Castro Lobo CL, Figueiredo MS, Menosi Gualandro SF, Olalla Saad ST, Cançado RD. da Silva Araújo A, et al. Among authors: menosi gualandro sf. Hemoglobin. 2024 Apr 25:1-13. doi: 10.1080/03630269.2024.2344790. Online ahead of print. Hemoglobin. 2024. PMID: 38663998 Review.
Novel Insights into the Pathophysiology and Treatment of Sickle Cell Disease.
Araújo ADS, Silva Pinto AC, Lobo CLC, Figueiredo MS, Menosi Gualandro SF, Olalla Saad ST, Cancado RD. Araújo ADS, et al. Among authors: menosi gualandro sf. Hemoglobin. 2023 Nov;47(2):71-79. doi: 10.1080/03630269.2023.2211771. Epub 2023 Jun 12. Hemoglobin. 2023. PMID: 37309063 Review.
Economic burden of sickle cell disease in Brazil.
Silva-Pinto AC, Costa FF, Gualandro SFM, Fonseca PBB, Grindler CM, Souza Filho HCR, Bueno CT, Cançado RD. Silva-Pinto AC, et al. Among authors: gualandro sfm. PLoS One. 2022 Jun 16;17(6):e0269703. doi: 10.1371/journal.pone.0269703. eCollection 2022. PLoS One. 2022. PMID: 35709301 Free PMC article.
Long-term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2-year results from two pivotal phase 3 studies.
Kulasekararaj AG, Griffin M, Langemeijer S, Usuki K, Kulagin A, Ogawa M, Yu J, Mujeebuddin A, Nishimura JI, Lee JW, Peffault de Latour R; 301/302 Study Group. Kulasekararaj AG, et al. Eur J Haematol. 2022 Sep;109(3):205-214. doi: 10.1111/ejh.13783. Epub 2022 Jun 16. Eur J Haematol. 2022. PMID: 35502600 Free PMC article. Clinical Trial.
Consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria.
Cançado RD, Araújo ADS, Sandes AF, Arrais C, Lobo CLC, Figueiredo MS, Gualandro SFM, Saad STO, Costa FF. Cançado RD, et al. Among authors: gualandro sfm. Hematol Transfus Cell Ther. 2021 Jul-Sep;43(3):341-348. doi: 10.1016/j.htct.2020.06.006. Epub 2020 Jul 6. Hematol Transfus Cell Ther. 2021. PMID: 32713742 Free PMC article.
Guidelines on the treatment of anemia of chronic renal failure using recombinant human erythropoietin: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira - 2014.
da Silva Araújo A, de Castro Lobo CL, Covas DT, Costa FF, Medeiros L, Cançado RD, Gualandro SF, Saad ST. da Silva Araújo A, et al. Among authors: gualandro sf. Rev Bras Hematol Hemoter. 2014 Nov-Dec;36(6):450-3. doi: 10.1016/j.bjhh.2014.09.009. Epub 2014 Oct 1. Rev Bras Hematol Hemoter. 2014. PMID: 25453659 Free PMC article. No abstract available.
14 results